NewLink Genetics Corp (NASDAQ:NLNK)

7.17
Delayed Data
As of 12:43pm ET
 +0.04 / +0.56%
Today’s Change
5.90
Today|||52-Week Range
25.17
-11.59%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close7.13
Today’s open7.17
Day’s range7.12 - 7.31
Volume171,615
Average volume (3 months)945,327
Market cap$263.6M
Data as of 12:43pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+9.98%
Earnings growth (next 5 years)+17.26%
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc+0.18+5.26%
SBBPStrongbridge Biophar...+0.15+2.26%
NEOSNeos Therapeutics In...+0.25+2.79%
DRRXDURECT Corp+0.03+2.75%
Data as of 12:56pm ET, 02/21/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts